ZEPP
Overvalued by 46.8% based on the discounted cash flow analysis.
Market cap | $10.03 Million |
---|---|
Enterprise Value | $120.06 Million |
Dividend Yield | $0 (0%) |
Earnings per Share | $-18.56 |
Beta | 0.84 |
Outstanding Shares | 3,855,750 |
Return on Equity | - |
---|---|
Return on Assets | - |
Return on Invested Capital | - |
P/E Ratio | -1.02 |
---|---|
PEG | 1.25 |
Price to Sales | 0.12 |
Price to Book Ratio | 0.09 |
Enterprise Value to Revenue | 0.66 |
Enterprise Value to EBIT | -2.02 |
Enterprise Value to Net Income | -2 |
Total Debt to Enterprise | 1.55 |
Debt to Equity | 0.8 |
No data
No data
Zepp Health's mission is to connect health with technology. Since its inception in 2013, the company has developed a platform of proprietary technology including AI chips, biometric sensors, and data algorithms, which drive a broadening ...